Collapse All

October 18, 2018

4:00 PM - 6:00 PM

Pre-Summit Symposium (By invitation only)

  • Description
  • This symposium will feature four in-depth presentations of new work in New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare. The audience will be limited to 50-60 people, including Friday speakers, Institutional Council, sponsor representatives, and selected other invitees, to allow for a very interactive session.  We expect this Thursday session to be an uncommon opportunity to preview and discuss research that will help shape the future of this area, as well as to network with the speakers and each other. 



    3:30 PM            Arrivals/Registration

    4:00 PM            Symposium (By invitation only)

    6:00 PM            Break

    6:30 PM            Social Hour and Dinner (By invitation only)

October 19, 2018

7:00 AM - 9:30 AM


October 19, 2018

8:30 AM - 9:30 AM

Keynote Address

  • Description
  • Mark McClellan, MD, PhD, Director of the Duke-Margolis Center for Health Policy and former FDA Commissioner and CMS Administrator, will provide his perspective on current policy and practice related to value-based pricing for drugs and other healthcare services. Dr. McClellan’s remarks will set the context for the day’s discussion and outline his thoughts on future directions in value assessment and pricing.

    With an introduction by Nancy Berg, ISPOR CEO

    Moderator: Federico Augustovski, MD, MSc, PhD, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina

October 19, 2018

9:30 AM - 10:30 AM

Current Value Frameworks – What’s New?

  • Description
  • Several value frameworks were introduced or gained prominence in the last several years, and each one has since undergone significant scrutiny and revision.  Representatives from ASCO, ICER, and the Faster Cures/Avalere Patient Perspective Value Framework will discuss recent developments for their approaches, accompanied by a payer perspective on how those and other frameworks are influencing payer deliberations.

    Moderated by Richard Willke, PhD, ISPOR

October 19, 2018

10:30 AM - 10:45 AM

Coffee Break

October 19, 2018

10:45 AM - 11:45 AM

Novel Approaches to Value Assessment, Within the Cost-Effectiveness Framework

  • Description
  • Our field has recently identified a number of aspects of how patients and society value treatments that are not typically accounted for in standard cost-effectiveness analysis. Analysts are exploring new approaches to measuring and incorporating these aspects to better reflect the full value of certain therapies. This session will highlight recent work in this area to foster discussion about areas where some useful modifications to cost-effectiveness analysis may be feasible and may offer new perspectives on value-based pricing.

    Moderated by Lou Garrison, PhD

October 19, 2018

11:45 AM - 12:45 PM


October 19, 2018

12:45 PM - 1:45 PM

Novel Approaches to Value Assessment, Beyond Cost-Effectiveness Framework

  • Description
  • There are a number of other approaches to weighing the benefits and costs of treatments that offer alternatives to cost-effectiveness analysis to support healthcare decision making and pricing. Recent developments in the use of multiple criteria decision analysis, patient preference measures, and non-QALY (quality-adjusted life year) measures of benefit will be presented and discussed in this session.

    Moderated by Shelby Reed, PhD, Duke University, Durham, NC

October 19, 2018

1:45 PM - 2:45 PM

Specific Value Assessment Considerations

  • Description
  • Any value measure must be used in a way that is appropriate to the specific decision and pricing context. This session will present and discuss recent thinking on indication-specific pricing, valuation of medical devices, implications of patient heterogeneity, and cases where health system affordability is a concern.

    Moderated by Sachin Kamal-Bahl, PhD, Pfizer, New York City, NY

October 19, 2018

2:45 PM - 3:00 PM


October 19, 2018

3:00 PM - 4:00 PM

Practical Next Steps in Improving Value Measurement and Use

  • Description
  • To reflect on and synthesize the learnings from the day’s sessions, a multi-stakeholder panel will be convened and discuss how improvements in measuring treatment value and using it in decision making can be carried forward in research, policy, pricing, utilization management, and practice guidelines.

    Moderated by Dan Ollendorf, PhD, CEVR, Tufts Medical Center, Boston, MA

October 19, 2018

4:00 PM - 4:30 PM

Closing Remarks

  • Description
  • Richard Willke, PhD, ISPOR, Lawrenceville, NJ